Antisense Therapeutics Limited (AU:ANP)

Antisense Therapeutics Limited Stock Price & Analysis


ANP Stock Chart & Stats

Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.07 - AU$0.21
Previous CloseAU$0.09
Average Volume (3M)399.70K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)-9.3
Next EarningsFeb 22, 2023
EPS Estimate-AU$0.01
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)>-0.01
Shares Outstanding669,043,978
Standard Deviation0.31
10 Day Avg. Volume1,179,938
30 Day Avg. Volume399,698
Price to Book (P/B)2.75
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)17.50
P/FCF Ratio-14875.20
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside310.64% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1


What was Antisense Therapeutics Limited’s price range in the past 12 months?
Antisense Therapeutics Limited lowest stock price was AU$0.07 and its highest was AU$0.21 in the past 12 months.
    What is Antisense Therapeutics Limited’s market cap?
    Currently, no data Available
    When is Antisense Therapeutics Limited’s upcoming earnings report date?
    Antisense Therapeutics Limited’s upcoming earnings report date is Feb 22, 2023 which is in 81 days.
      How were Antisense Therapeutics Limited’s earnings last quarter?
      Antisense Therapeutics Limited released its earnings results on Aug 31, 2022. The company reported -AU$0.004 earnings per share for the quarter, beating the consensus estimate of -AU$0.01 by AU$0.006.
        Is Antisense Therapeutics Limited overvalued?
        According to Wall Street analysts Antisense Therapeutics Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Antisense Therapeutics Limited pay dividends?
          Antisense Therapeutics Limited does not currently pay dividends.
          What is Antisense Therapeutics Limited’s EPS estimate?
          Antisense Therapeutics Limited’s EPS estimate is -AU$0.01.
            How many shares outstanding does Antisense Therapeutics Limited have?
            Antisense Therapeutics Limited has 669,044,000 shares outstanding.
              What happened to Antisense Therapeutics Limited’s price movement after its last earnings report?
              Antisense Therapeutics Limited reported an EPS of -AU$0.004 in its last earnings report, beating expectations of -AU$0.01. Following the earnings report the stock price went up 5.814%.
                Which hedge fund is a major shareholder of Antisense Therapeutics Limited?
                Currently, no hedge funds are holding shares in AU:ANP


                Antisense Therapeutics Limited Stock Smart Score

                The Antisense Therapeutics Limited Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Antisense Therapeutics Limited

                Antisense Therapeutics Ltd. engages in the research and development of novel antisense pharmacceuticals. It operates through the ATL1102, and ATL1103 segments. The ATL1102 segment represents the second generation antisense inhibitor of CD49d, the alpha subunit of very late antigen-four. The ATL1103 segment refers to atesidorsen is an antisense drug designed to block growth hormone receptor expression thereby reducing levels of the hormone insulin. The company was founded in November 13, 2000 and is headquartered in Toorak, Australia.


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Vita Life Sciences Limited
                Botanix Pharmaceuticals Limited
                Emyria Ltd
                Argenica Therapeutics Ltd
                Little Green Pharma Ltd.

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis